An estimated 90 percent of individuals with inherited cancer risk do not know they are at risk.
Providence is evaluating new models for identifying patients eligible for hereditary cancer risk assessment and genetic testing.
Testing of an AI chatbot to identify eligible patients and improve access to genetic testing and counseling at seven CA sites led to a 10-fold increase in genetic testing compared to paper screenings.
Providence continues expanding the initiative at sites in Southern California and Washington State.
Learn about our Prevention4ME program
